Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 22, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Rescoring the NIH chronic prostatitis symptom index: nothing new.

J Q Clemens1, E A Calhoun, M S Litwin

  • 1Department of Urology, University of Michigan Medical Center, Ann Arbor, MI 48109-5330, USA. qclemens@umich.edu

Prostate Cancer and Prostatic Diseases
|June 3, 2009
PubMed
Summary

The National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) scoring was revised for equal item weighting. While offering slightly better internal consistency and face validity, the rescored version showed marginal performance improvements over the standard method.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Care and Education Professionals' Breastfeeding Knowledge and Practices Before and After an E-Learning Program.

Journal of health science & education·2024
Same author

Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry.

BMC urology·2023
Same author

Correlates of 1-Year Change in Quality of Life in Patients with Urologic Chronic Pelvic Pain Syndrome: Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

The Journal of urology·2020
Same author

Urinalysis in patients with neuromyelitis optica spectrum disorder.

European journal of neurology·2019
Same author

Reply by Authors.

The Journal of urology·2019
Same author

Characteristics of antimicrobial stewardship programmes in rural East Texas hospitals.

The Journal of hospital infection·2018

Area of Science:

  • Urology
  • Medical Assessment Tools
  • Pain Management

Background:

  • The National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) is a standard tool for assessing chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
  • The current NIH-CPSI scoring system assigns unequal weights to items due to varying score ranges, potentially impacting questionnaire performance.
  • Unequal weighting may lead to de facto overemphasis on certain items, affecting the overall accuracy of symptom severity assessment.

Purpose of the Study:

  • To investigate the impact of revising the NIH-CPSI scoring algorithm to assign equal weights to each item.
  • To compare the performance characteristics of the standard NIH-CPSI scoring versus a newly proposed equal-weight scoring system.
  • To evaluate if a rescored NIH-CPSI offers significant improvements in validity and reliability for CP/CPPS assessment.

More Related Videos

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
06:46

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

Related Experiment Videos

Last Updated: Jun 22, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
06:46

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis

Published on: January 16, 2013

Main Methods:

  • The NIH-CPSI was rescored to ensure each item contributed equally to the total score.
  • The performance of the standard and rescored NIH-CPSI algorithms was compared using an original validation dataset.
  • Statistical analysis included comparing discrimination among patient groups (CP/CPPS, benign prostatic hyperplasia, controls) and assessing internal consistency (Cronbach's alpha).

Main Results:

  • Both the standard and rescored NIH-CPSI algorithms demonstrated similar ability to discriminate between men with CP/CPPS, benign prostatic hyperplasia, and controls.
  • The revised scoring algorithm showed a slight improvement in internal consistency compared to the standard scoring.
  • However, the internal consistency with the standard scoring was already high (Cronbach's >or=0.80), and improvements with the revised scoring were marginal.

Conclusions:

  • Rescoring the NIH-CPSI to achieve equal item weighting provides enhanced face validity.
  • The revised scoring method requires additional computational effort.
  • The performance improvements offered by the rescored NIH-CPSI are marginal, suggesting the standard scoring remains largely effective.